Revolutionizing microscopy with affordable high-resolution techniques

Researchers at the University of Illinois at Urbana-Champaign have shown for the first time that expensive aberration-corrected microscopes are no longer required to achieve record-breaking microscopic resolution.

Drug-Related Endocarditis: A First Stab at Recommendations for Surgeons

SAN ANTONIO — In response to the opioid epidemic, a primer to treating infective endocarditis (IE) specifically related to drug use was released by the

January 31, 2024

Did Sarepta Therapeutics earn $4 billion from exon-skipping drugs that don’t work?

This is the online edition of Adam’s Biotech Scorecard, a subscriber-only newsletter. STAT+ subscribers can sign up here to get it delivered every Thursday to their

May 30, 2024

Immunovant’s plans for autoimmune asset; Wall Street worries about Moderna’s RSV candidate

Plus, news about Novo Holdings, Gritstone Bio, Invivyd and Science 37: Immunovant outlines big plans for its autoimmune program: The biotech now expects to launch

February 13, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.